Gen-Probe Reports Financial Results for Second Qu...(are data) ...),Health

Date:7/30/2009

are data) (Unaudited) Six Months Ended June 30, 2009 ------------- Non-GAAP Adjustments GAAP -------- ----------- ---- Revenues: Product sales $229,338 $- $229,338 Collaborative research revenue 3,862 - 3,862 Royalty and license revenue 3,528 - 3,528 ----- ----- ----- Total revenues 236,728 - 236,728 Operating expenses: Cost of product sales (excluding acquisition- related intangibles amortization) 71,504 90 71,594 Acquisition-related intangibles amortization - 1,114 1,114 Research and development 51,067 - 51,067 Marketing and sales 25,070 - 25,070 General and administrative 26,864 4,806 31,670 ------ ----- ------ Total operating expenses 174,505 6,010 180,515 ------- ----- ------- Income from operations 62,223 (6,010) 56,213 Other income/(expense): Interest income 15,004 - 15,004 Interest expense (877) - (877) Other income/(expense) (1,037) - (1,037) ------ ----- ------ Total other income, net 13,090 - 13,090
'/>"/>

SOURCE Gen-Probe Incorporated Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22
Related medicine news :

1. Gen-Probe to Webcast Two Upcoming Investor Presentations
2. Gen-Probe Reports Financial Results for First Quarter 2009
3. Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
4. Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer
5. Tepnel Shareholders Approve Acquisition by Gen-Probe
6. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
7. Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash
8. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
9. Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
10. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
11. Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference